Claim OwnershipThe Stem Cell Podcast
Subscribed: 1,003Played: 13,731
Subscribe
Description
Join Drs. Daylon James and Arun Sharma as they discuss the latest stem cell research, and interview some of the brightest minds in the field.
261 Episodes
Reverse
Dr. Aileen Anderson is the Director of the Sue and Bill Gross Stem Cell Research Center at the University of California, Irvine. Her lab investigates the role of inflammatory mechanisms in degeneration and regeneration in the injured central nervous system. She talks about cell therapy for spinal cord injury and how academic labs can collaborate with companies to move toward the clinic. She also discusses biomaterials to support axon regeneration.
Dr. Shannon McKinney-Freeman is a Principal Investigator and Member at St. Jude Children's Research Hospital. Her lab focuses on the fundamental biology of hematopoietic stem cells (HSCs). She talks about the role of HSCs in sickle cell disease and the state of HSC transplantation research. She also discusses her work on hematopoietic progenitor expansion.
Dr. Sergiu Pașca is the Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences at Stanford University and the Bonnie Uytengsu and Family Director of the Stanford Brain Organogenesis Program. His lab has pioneered and applied neural organoid and assembloid technologies to make discoveries in fundamental and clinical neuroscience. He talks about the response to his viral TED Talk and the importance of names for nervous system models. He also discusses CRISPR screening in assembloids to study autism, transplanting cortical organoids into rats, and biocompatible polymers for neural organoids.
Dr. Stylianos Lefkopoulos is an Associate Editor of Nature Cell Biology. He talks about a day in the life of an editor and what he looks for in a manuscript. He also discusses the role of preprints in publishing and promoting diversity in STEM.
Dr. Noriaki Ono is an Associate Professor at the University of Texas Health Center at Houston. His research focuses on bone development and regeneration. He talks about in vivo lineage tracing techniques and how early perichondrial cells contribute to developing bones. He also discusses the art and science of dentistry, mentorship, and moving his lab across the country.
Dr. Ryan Conder is the Director of Epithelial and Organoid Systems at STEMCELL Technologies. He talks about the next phase in organoid research and what questions organoids can help answer. He also discusses his experience doing a postdoc in Vienna, and Vancouver as a growing biotech hub.
1Keith Alm is the CEO, Dr. Haifan Lin is the President, and Dr. David Scadden is 2023 Annual Meeting Program Chair of the ISSCR. They talk about the upcoming annual meeting being held this year in Boston, a biotech hub with a vibrant stem cell research community. They discuss the highlights of this year's program including speakers, award winners, and more. They also discuss making this year's meeting more accessible to trainees and researchers around the world.
Dr. Lorenz Studer is the Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Institute. His lab exploits recent advances in stem cell biology to develop new therapies for degenerative diseases and cancer. Their projects involve directing the fate and age of hPSCs, modeling diseases, and developing cell therapies. He talks about his journey into the stem cell field and co-founding BlueRock Therapeutics. He also discusses the challenges of developing cell therapies at scale, strategies to target cognition loss in Parkinson's disease, and combining basic and translational research.
Dr. Boyang Zhang is an Assistant Professor of Chemical Engineering at McMaster University. His lab uses advanced biofabrication techniques to build human micro-tissue models for predictive drug discovery and to construct functional macro-tissues for tissue regeneration in patients. He talks about building microfluidic devices for biological applications and using machine learning to study organoid morphology. He also talks about his team's high-throughput system for vascularizing tissue spheroids and his experience starting a company to commercialize this technology.
In this special episode, Daylon and Arun chat with Drs. Jason Goldsmith and Brenda Raud, the hosts of The Immunology Podcast. Recorded in-person and led by Dr. Nicole Quinn from STEMCELL Technologies, the four hosts discuss the impact that podcasting has had on their careers and how it can make science and scientists more accessible. They also talk about the future of science communication and advice for young scientists pursuing careers in academia and industry.
Dr. Clive Svendsen is the Executive Director of the Regenerative Medicine Institute at Cedars-Sinai. His lab uses stem cells to develop models and treatments for neurodegenerative diseases. He talks about using stem cells to model spinal muscular atrophy and the blood-brain barrier, and his cell-gene therapy trial for ALS.
Dr. Shuibing Chen is the Kilts Family Professor of Surgery at Weill Cornell Medicine. Her lab uses hiPSCs and ESCs for disease modeling and drug screening, with a focus on diabetes and infectious diseases such as Zika and SARS-CoV-2. She talks about her recent genome-wide association study in a dish, the role of philanthropic funding in stem cell research, and the role of industry partnerships in translational research.
Dr. Paola Arlotta is the Golub Family Professor of Stem Cell and Regenerative Biology at Harvard University. She is interested in understanding the molecular laws that govern the birth, differentiation, and assembly of the human brain’s cerebral cortex. She talks about using organoids to study the genetics of autism. She also discusses single-cell sequencing of brain organoids and how to make single-cell sequencing methods and data more accessible.
Dr. Jacob Hanna is an Associate Professor at the Weizmann Institute of Science. His lab investigates cellular reprogramming and embryogenesis. He talks about the challenges of growing synthetic embryo models in a roller culture system and the feasibility of making human gametes. He also discusses his startup, Renewal Bio, the ethical discussions surrounding stem cell-derived embryos, and creating a more inclusive and equitable scientific community.
Dr. Stefan Irion is the Senior Vice President of Research at BlueRock Therapeutics, a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. He talks about the company's Parkinson's disease trial and the challenges of genetically manipulating stem cells. He also discusses his journey from physician to scientist and his personal connection to Parkinson's disease.
Dr. Jun Wu is an Assistant Professor at the University of Texas Southwestern. The Wu lab uses interspecies chimeras to study fundamental biology: conserved and divergent developmental programs, determination of body and organ size, species barriers, and cancer resistance. They are also working to develop new applications for regenerative medicine. He talks about developmental compatibility between species, and the similarities and differences between blastoid models and blastocyts. He also discusses the challenges of growing human cells in animals, and human-monkey chimeric embryos.
Dr. Edward Grow is an Assistant Professor at the University of Texas, Southwestern. His lab studies reproductive biology, specifically the development of the egg and subsequently the fertilized embryo. He talks about regulating totipotency in ESCs, retroviral reactivation, and ex vivo culturing of follicles and oocytes.
Dr. Prisca Liberali is Senior Group Leader at the Friedrich Miescher Institute for Biomedical Research and an Assistant Professor at the University of Basel. Her research aims to understand the collective properties of organoid systems and their patterns, including how these systems allow systematic perturbation by established methods for modulating gene expression. She studies self-organization, symmetry breaking, intestinal organoid development, gastruloids, and mechanosensing mechanisms.
Drs. Tenneille Ludwig, Peter Andrews, and Madeline Lancaster are members of the ISSCR Standards Initiative for Pluripotent Stem Cell Research. They discuss the need for basic and preclinical standards to ensure rigor and reproducibility in stem cell research. They also talk about standards for pluripotency and model systems, and the initiative's international focus.
Dr. Jackie Damen is a currently a Principal Scientist in Scientific Support for Hematology at STEMCELL Technologies, and was previously the Director of Contract Assay Services. She talks about the company's culture and growth, and how in her role, she teaches scientists and helps them conduct their experiments. She also discusses systems for drug screening and discovery, opportunities in industry, and her affinity for microscopy and photography.
Download from Google Play
Download from App Store
United States
Proud of you Leili👍🏻
greeting from Colombia